Phase II trial of adjuvant chemotherapy with modified medication of S-1 for pancreatic cancer.
Phase of Trial: Phase II
Latest Information Update: 18 May 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 13 May 2016 Status changed from not yet recruiting to completed.
- 02 Dec 2009 New trial record